A clinical-stage biotechnology company focused on developing therapies for urological and related disorders. Its pipeline has centered on compounds targeting conditions such as overactive bladder, with value largely tied to clinical trial outcomes and potential regulatory approvals. Investors monito...
This page tracks all publicly disclosed congressional trades in Velicept Therapeutics, Inc. (VETH), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
No congressional trades found for this stock.